marcus evans europe conferences

11th Annual Commercial Translation of Regenerative Medicine

Realise the Dream of Regenerative Medicine – Rediscover Your Potential For Commercialisation

25-26 November 2013
Charing Cross Hotel, London, United Kingdom

Conference Workshop

Interactive Workshop:

Understanding Smart Manufacturing and Bioprocessing from QbD to Scaling-up

Workshop Moderator: Sarah Callens

Company: Head of Process Development, Cell Therapy Catapult

Why You Should Attend

11th Annual Commercial Translation of Regenerative Medicine

Growing year on year, the 11th Annual Commercial Translation of Regenerative Medicine Conference will delve into the current business challenges that are holding up commercialisation. This conference will help delegates see their potential through significant growth, considerable financial return and market access. Since regenerative medicine poses high risk to investors, the conference will also demonstrate the business strategies that are needed to mitigate risk from research, manufacturing to commercialisation. With new sources of revenue and novel technologies coming into place, the industry is keen on understanding how to capture and incorporate these into their business. Addressing the current regulatory landscape, delegates will also gain a holistic global oversight of the uncertainties the future may behold.


By attending this Commercial Translation of Regenerative Medicine Conference, delegates will benefit from understanding how to overcome funding, regulatory and manufacturing challenges for smooth transition into the market. Importantly, regenerative medicine is attracting the involvement of leading pharmaceutical players this conference will look into their strategies and role in the industry. Come and share your experiences with leading decision makers to streamline your clinical success!


Key Topics

  • Grasp the best business strategies to secure the future of your regenerative medicine products
  • Learn how new technologies and existing tools can be applied to commercial manufacturing
  • Update yourself on the regulatory progress and reimbursement considerations
  • Gain insight from the pharma perspective and design a road map to collaboration
  • Leverage experiences from leading regenerative medicine companies and decision makers

  • Why Choose marcus evans?

    marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.

    Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.

    Event Sponsors
    apceth GmbH & Co. KG
    Visit website >>

    Event Partners

    Practical Insights From

    Prof. Chris Mason
    Chair of Regenerative Medicine Bioprocessing, Stem Cell & Regenerative Medicine Bioprocessing Unit, Advanced Centre for Biochemical Engineering
    University College London, UK

    Geoff MacKay
    President & CEO

    Jim Faulkner
    Vice President, CMC & Supply, Rare Diseases Unit

    Mark Zimmerman
    Vice President, Venture Leader
    Janssen Research and Development, LLC

    Eric Halioua
    Promethera Biosciences

    Martin Guttridge
    NHS Core Blood Bank Manager & Processing Facility Director
    NHS Blood and Transplant

    Michael D. West
    BioTime, Inc.

    Paul Kemp
    CEO, CSO

    Click Here For Full Agenda

    Voice of Our Customers
    Join the Discussion

    Event Contact

    For all enquiries regarding speaking, sponsoring and attending this conference contact:

    Kristiyan Sokolov

    PO Box 24797
    CY-1304 Nicosia

    +357 22 849 408
    Fax: +357 22849 394